Publication | Closed Access

Sodium butyrate ameliorates S100/FCA-induced autoimmune hepatitis through regulation of intestinal tight junction and toll-like receptor 4 signaling pathway

InflammationMolecular ImmunologyAutoimmune DiseaseMucosal ImmunologyMedicineIntestinal Tight JunctionImmunologyImmune RegulationPathologyAutoimmunityImmunotherapySodium ButyrateAutoimmune Liver DiseaseS100/fca-induced Autoimmune Hepatitis